Plasma lipidome reveals critical illness and recovery from human Ebola virus disease

Ebola virus disease (EVD) often leads to severe and fatal outcomes in humans with early supportive care increasing the chances of survival. Profiling the human plasma lipidome provides insight into critical illness as well as diseased states, as lipids have essential roles as membrane structural com...

Full description

Saved in:
Bibliographic Details
Published inProceedings of the National Academy of Sciences - PNAS Vol. 116; no. 9; pp. 3919 - 3928
Main Authors Kyle, J. E., Burnum-Johnson, K. E., Wendler, J. P., Eisfeld, A. J., Halfmann, Peter J., Watanabe, Tokiko, Sahr, Foday, Smith, R. D., Kawaoka, Y., Waters, K. M., Metz, T. O.
Format Journal Article
LanguageEnglish
Published United States National Academy of Sciences 26.02.2019
SeriesPNAS Plus
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Ebola virus disease (EVD) often leads to severe and fatal outcomes in humans with early supportive care increasing the chances of survival. Profiling the human plasma lipidome provides insight into critical illness as well as diseased states, as lipids have essential roles as membrane structural components, signaling molecules, and energy sources. Here we show that the plasma lipidomes of EVD survivors and fatalities from Sierra Leone, infected during the 2014–2016 Ebola virus outbreak, were profoundly altered. Focusing on how lipids are associated in human plasma, while factoring in the state of critical illness, we found that lipidome changes were related to EVD outcome and could identify states of disease and recovery. Specific changes in the lipidome suggested contributions from extracellular vesicles, viremia, liver dysfunction, apoptosis, autophagy, and general critical illness, and we identified possible targets for therapies enhancing EVD survival.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
PNNL-SA-136689
National Institute of Allergy and Infectious Diseases (NIAID)
Emerging/Re-Emerging Infectious Diseases Project of Japan
National Institutes of Health (NIH)
USDOE Office of Science (SC), Biological and Environmental Research (BER)
Ministry of Education, Culture, Sports, Science and Technology (MEXT)
AC05-76RL01830; 16H06429; 6K21723; 16H06434; U19AI106772; P41 GM103493
Health and Labor Sciences Research
National Institute of General Medical Sciences (NIGMS)
Edited by David W. Russell, University of Texas Southwestern Medical Center, Dallas, TX, and approved December 31, 2018 (received for review September 7, 2018)
Author contributions: J.E.K., A.J.E., F.S., R.D.S., Y.K., K.M.W., and T.O.M. designed research; J.E.K., A.J.E., P.J.H., and T.W. performed research; J.E.K., K.E.B.-J., and J.P.W. analyzed data; and J.E.K., A.J.E., K.M.W., and T.O.M. wrote the paper.
ISSN:0027-8424
1091-6490
1091-6490
DOI:10.1073/pnas.1815356116